Cancer Biomarkers Market By Region - Global Forecast - 2023
Cancer Biomarkers Market - Segmented By Disease, By Services, By Application, By Type, By Profiling Technologies & By Region - Global Forecast - 2023
(EMAILWIRE.COM, November 23, 2018 ) Cancer Biomarkers Market overview
Biomarkers are chemical, physical or biological parameters which can be used to identify disease states. Oncology biomarkers recommends high speed, non invasive cancer diagnosis and deem to improve cancer detection and screening. Biomarker research is increasing high importance these days owing to its benefits such as accurate detection, easier diagnosis, and low chances of misdiagnosis during early cancer diagnosis. Comparison of cancer biomarkers at two different sites is very helpful for identifying metastatic tumours. Many different types of biomarkers have been characterized earlier and are in use in numerous cancer diagnostic testing procedures.
Request for Sample @ https://www.marketdataforecast.com/market-reports/cancer-biomarkers-market-2239/request-sample/
Key driving factors for the market are restructured drug delivery procedure, non invasive technology, augmented rates of survival. Boost in government and private funding for oncology also fuels the market development. Market is constrained by high cost of diagnosis, issues linked to reimbursement and some of the regulatory policies which hamper the market growth.
Cancer Biomarkers Market Forecast Report (2018-2023)
Global Cancer Biomarkers Market worth was USD 12.86 billion in 2018 and estimated to be growing at a CAGR of 11.45%, to reach USD 22.11 billion by 2023.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/cancer-biomarkers-market-2239/
Global cancer biomarkers Market Segmentation
Global cancer biomarkers is segmented on the basis of disease into Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers. Based on facilities market is divided into Sample Preparation, Assay development and Biomarkers validation and testing. On the base of application, market is bifurcated into Risk Assessment, Development of molecular diagnostics, Disease diagnosis, Drug discovery and Development and Drug formulation. By Type, the cancer biomarkers market is separated into Protein Biomarkers, Genetic biomarkers and other biomarkers. Based on profiling technologies, segmentation is between omics technologies, Imaging technologies, Immunoassays, Cytogenetics, Bioinformatics and IVD multivariate index assays. Omics technologies sector is further sub segmented into Genomics, Proteomics, Metabolomics, Transcriptomics and Pharmacogenomics.
Based on geography, the market is analysed under different regions namely, North America, Europe, Latin America, Asia-Pacific and Middle-East & Africa. The Asia-Pacific market is poised to record the maximum growth rate in the forecast period due to the supporting government funding for cancer biomarker research, increasing prevalence of cancer, rising demand for advanced healthcare facilities in developing economies such as India and China, growing number of clinical trials, and rising focus of international players in emerging markets.
Key Developments in the Market
January 2018: Roche and GE entered into a partnership to expand integrated digital diagnostics platform to improve oncology and critical care treatment. This partnership will relate advanced analytics to in-vivo data from GEs medical imaging and monitoring equipment with in-vitro data from Roches biomarker, tissue pathology, genomics, and sequencing portfolio.
January 2018: New biomarkers establish for colorectal cancer (MYO5B).
Buy now@ https://www.marketdataforecast.com/cart/buy-now/cancer-biomarkers-market-2239/
Major Players:
Some of the major companies in this cancer biomarkers market are
Abbott Laboratories,
Agendia Bv
Biocurex Inc
Biomerieux S.A.
Biomoda Inc
Astellas Pharma Us Inc
Correlogic Systems Inc
Beckman Coulter Inc
Becton
Dickinson And Company
Clarient Inc
Diadexus Inc
Ambrilia Biopharma
Affymetrix Inc and Aureon Laboratories Inc
Shxchangyu
Customize Report@ https://www.marketdataforecast.com/market-reports/cancer-biomarkers-market-2239/customize-report/
About Us
Market Data Forecast is a determined working in the areas of market research, business intelligence and consulting. We have great experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
For more information:
Abhishek Shukla
Sales Manager at Market Data Forecast
Email: abhishek@marketdataforecast.com
Tel: +1-888-702-9626
Website: www.marketdataforecast.com
Biomarkers are chemical, physical or biological parameters which can be used to identify disease states. Oncology biomarkers recommends high speed, non invasive cancer diagnosis and deem to improve cancer detection and screening. Biomarker research is increasing high importance these days owing to its benefits such as accurate detection, easier diagnosis, and low chances of misdiagnosis during early cancer diagnosis. Comparison of cancer biomarkers at two different sites is very helpful for identifying metastatic tumours. Many different types of biomarkers have been characterized earlier and are in use in numerous cancer diagnostic testing procedures.
Request for Sample @ https://www.marketdataforecast.com/market-reports/cancer-biomarkers-market-2239/request-sample/
Key driving factors for the market are restructured drug delivery procedure, non invasive technology, augmented rates of survival. Boost in government and private funding for oncology also fuels the market development. Market is constrained by high cost of diagnosis, issues linked to reimbursement and some of the regulatory policies which hamper the market growth.
Cancer Biomarkers Market Forecast Report (2018-2023)
Global Cancer Biomarkers Market worth was USD 12.86 billion in 2018 and estimated to be growing at a CAGR of 11.45%, to reach USD 22.11 billion by 2023.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/cancer-biomarkers-market-2239/
Global cancer biomarkers Market Segmentation
Global cancer biomarkers is segmented on the basis of disease into Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers. Based on facilities market is divided into Sample Preparation, Assay development and Biomarkers validation and testing. On the base of application, market is bifurcated into Risk Assessment, Development of molecular diagnostics, Disease diagnosis, Drug discovery and Development and Drug formulation. By Type, the cancer biomarkers market is separated into Protein Biomarkers, Genetic biomarkers and other biomarkers. Based on profiling technologies, segmentation is between omics technologies, Imaging technologies, Immunoassays, Cytogenetics, Bioinformatics and IVD multivariate index assays. Omics technologies sector is further sub segmented into Genomics, Proteomics, Metabolomics, Transcriptomics and Pharmacogenomics.
Based on geography, the market is analysed under different regions namely, North America, Europe, Latin America, Asia-Pacific and Middle-East & Africa. The Asia-Pacific market is poised to record the maximum growth rate in the forecast period due to the supporting government funding for cancer biomarker research, increasing prevalence of cancer, rising demand for advanced healthcare facilities in developing economies such as India and China, growing number of clinical trials, and rising focus of international players in emerging markets.
Key Developments in the Market
January 2018: Roche and GE entered into a partnership to expand integrated digital diagnostics platform to improve oncology and critical care treatment. This partnership will relate advanced analytics to in-vivo data from GEs medical imaging and monitoring equipment with in-vitro data from Roches biomarker, tissue pathology, genomics, and sequencing portfolio.
January 2018: New biomarkers establish for colorectal cancer (MYO5B).
Buy now@ https://www.marketdataforecast.com/cart/buy-now/cancer-biomarkers-market-2239/
Major Players:
Some of the major companies in this cancer biomarkers market are
Abbott Laboratories,
Agendia Bv
Biocurex Inc
Biomerieux S.A.
Biomoda Inc
Astellas Pharma Us Inc
Correlogic Systems Inc
Beckman Coulter Inc
Becton
Dickinson And Company
Clarient Inc
Diadexus Inc
Ambrilia Biopharma
Affymetrix Inc and Aureon Laboratories Inc
Shxchangyu
Customize Report@ https://www.marketdataforecast.com/market-reports/cancer-biomarkers-market-2239/customize-report/
About Us
Market Data Forecast is a determined working in the areas of market research, business intelligence and consulting. We have great experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
For more information:
Abhishek Shukla
Sales Manager at Market Data Forecast
Email: abhishek@marketdataforecast.com
Tel: +1-888-702-9626
Website: www.marketdataforecast.com
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results